Briefly, Wnt ligands released by cancer cells induce the canonical Wnt signaling pathway, whose hallmark is the accumulation of β-catenin protein into the nucleus, thereby leading to the inhibition of CD8+ T-cell infiltration within the TME and production of Treg cells with subsequent inhibition of cytotoxic T-cell activity. This evidence concerns the gene CD8A and cancer.